• PULSE Challenge: The Discovery of Seqitope and Opti-mAb Technologies

    The Seqitope® and Opti-Mab® technologies originated from projects together with SciLifeLab DDD. Seqitope® is a high-resolution epitope mapping platform that combines large-scale wet-lab screening with advanced bioinformatics. By utilizing phage display of libraries containing millions of mutated antigen variants, it goes far beyond classical alanine scanning

    Drug Discovery and Development Platform (DDD)
    Online event via Zoom

    PULSE Challenge: Catalysis – A guiding principle for biochemistry and professional career development

    This seminar will describe Dr. Lorenz M. Mayr's experience in drug discovery from over 30 years in industry, academia, venture capital/financing and finally running Biotech startup companies. He is driven by his passion for science, interdisciplinary research and impact for patients. The ultimate goal has always been to bring innovative, impactful and affordable medicine to patients.

    Drug Discovery and Development Platform (DDD)
    Online event via Zoom